Labeler
Rigel Pharmaceuticals, Inc. NDC Codes
Rigel Pharmaceuticals, Inc. lists 6 finished drug products in the FDA NDC Directory under NDC labeler code 71332.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Vepdegestrant, Fostamatinib, Pralsetinib, Olutasidenib
- NDC labeler codes
- 71332
- Strengths
- Vepdegestrant 100 mg/1; Vepdegestrant 200 mg/1; Pralsetinib 100 mg/1; Olutasidenib 150 mg/1; Fostamatinib 100 mg/1; Fostamatinib 150 mg/1
- Dosage forms
- Tablet, Film coated, Capsule, Tablet
- Routes
- Oral
- Drug classes (FDA established)
- Kinase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 8
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Veppanuvepdegestrant | Vepdegestrant 100 mg/1 | Tablet, Film coatedOral | 71332-007 | 71332-0007-30 | — |
| Veppanuvepdegestrant | Vepdegestrant 200 mg/1 | Tablet, Film coatedOral | 71332-008 | 71332-0008-30 | — |
| Gavretopralsetinib | Pralsetinib 100 mg/1 | CapsuleOral | 71332-006 | 71332-0006-1271332-0006-6071332-0006-90 | — |
| Rezlidhiaolutasidenib | Olutasidenib 150 mg/1 | CapsuleOral | 71332-005 | 71332-0005-01 | — |
| Tavalissefostamatinib | Fostamatinib 100 mg/1 | TabletOral | 71332-001 | 71332-0001-01 | — |
| Tavalissefostamatinib | Fostamatinib 150 mg/1 | TabletOral | 71332-002 | 71332-0002-01 | — |
Rigel Pharmaceuticals, Inc.: common questions
- What is Rigel Pharmaceuticals, Inc.'s NDC labeler code?
- 71332. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Rigel Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.